It was only in the early 1990s that researchers first infused GLP-1 intravenously in a clinical trial
Semaglutide GLP-1 enhances insulin release, particularly when blood sugar levels are elevated, thereby aiding in better glucose control
Skin purging is a reaction to an active ingredient that speeds up skin cell turnover rate
(2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Recent advances have completely transformed the way breast cancer is treated and continue to evolve at an unprecedented pace focused on proportionate reduction of overtreatment and developing more precision and personalized treatment with few minimal side effects within clinics